Tai-Wei Chen1,2, Chun-Yang Huang1, Po-Lin Chen1,2, Chiu-Yang Lee1, Chun-Che Shih1,3, I-Ming Chen1,2. 1. Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital. 2. Department of Medicine. 3. Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Abstract
BACKGROUND: Treatment for extensive aortoiliac occlusive disease (AIOD) includes endovascular interventions, hybrid procedures and surgical reconstruction. This study evaluated the short-term outcomes of endovascular and hybrid procedures in patients with Trans-Atlantic Inter-Society Consensus II (TASC-II) D AIOD lesions. MATERIALS AND METHODS: From January 2013 to June 2015, 41 patients with TASC-II D AIOD lesions who underwent revascularization at our institute were retrospectively included. Nineteen underwent endovascular procedures and 22 underwent hybrid procedures with a postoperative surveillance program for at least 1 year. Patient demographics and short-term outcomes were analyzed. RESULTS: The procedural success rate in all patients was 100%. The accumulative postoperative complication rate was 20.2%, and the major complication was acute kidney injury (14.6%). The time of freedom from target lesion revascularization was 18.9 months. The primary patency rates in the endovascular group were 89.5% and 84.2% at 1 and 2 years, respectively, compared to 95.5% at 1 and 2 years in the hybrid group; however, the difference was not significant (p = 0.234). The secondary patency rates were 94.7% and 93% at 1 and 2 years, respectively, in the endovascular group, and 95.5% and 94% at 1 and 2 years, respectively, in the hybrid group; however, the differences was not significant (p = 0.916). CONCLUSIONS: Our study revealed that endovascular and hybrid procedures are favorable treatment choices for patients with TASC-II D AIOD lesions. In patients with multilevel steno-occlusive lesions, hybrid procedures improved distal runoff flow and reduced the complexity of endovascular procedures.
BACKGROUND: Treatment for extensive aortoiliac occlusive disease (AIOD) includes endovascular interventions, hybrid procedures and surgical reconstruction. This study evaluated the short-term outcomes of endovascular and hybrid procedures in patients with Trans-Atlantic Inter-Society Consensus II (TASC-II) D AIOD lesions. MATERIALS AND METHODS: From January 2013 to June 2015, 41 patients with TASC-II D AIOD lesions who underwent revascularization at our institute were retrospectively included. Nineteen underwent endovascular procedures and 22 underwent hybrid procedures with a postoperative surveillance program for at least 1 year. Patient demographics and short-term outcomes were analyzed. RESULTS: The procedural success rate in all patients was 100%. The accumulative postoperative complication rate was 20.2%, and the major complication was acute kidney injury (14.6%). The time of freedom from target lesion revascularization was 18.9 months. The primary patency rates in the endovascular group were 89.5% and 84.2% at 1 and 2 years, respectively, compared to 95.5% at 1 and 2 years in the hybrid group; however, the difference was not significant (p = 0.234). The secondary patency rates were 94.7% and 93% at 1 and 2 years, respectively, in the endovascular group, and 95.5% and 94% at 1 and 2 years, respectively, in the hybrid group; however, the differences was not significant (p = 0.916). CONCLUSIONS: Our study revealed that endovascular and hybrid procedures are favorable treatment choices for patients with TASC-II D AIOD lesions. In patients with multilevel steno-occlusive lesions, hybrid procedures improved distal runoff flow and reduced the complexity of endovascular procedures.
Entities:
Keywords:
Aorto-iliac occlusive disease; Hybrid operation; TASC-II D lesion
Authors: J C Palmaz; C E Encarnacion; O J Garcia; R A Schatz; F J Rivera; J C Laborde; S P Dougherty Journal: J Vasc Interv Radiol Date: 1991-08 Impact factor: 3.464
Authors: Erik Groot Jebbink; Frederike A B Grimme; Peter C J M Goverde; Jacques A van Oostayen; Cornelis H Slump; Michel M P J Reijnen Journal: J Vasc Surg Date: 2014-01-29 Impact factor: 4.268
Authors: Bibombe P Mwipatayi; Surabhi Sharma; Ali Daneshmand; Shannon D Thomas; Vikram Vijayan; Nishath Altaf; Marek Garbowski; Mark Jackson Journal: J Vasc Surg Date: 2016-04-28 Impact factor: 4.268
Authors: F A B Grimme; P C J M Goverde; P J E M Verbruggen; C J Zeebregts; M M P J Reijnen Journal: Eur J Vasc Endovasc Surg Date: 2015-09-03 Impact factor: 7.069